Where does AtaCor Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AtaCor Medical, Inc. ranks #9,972 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AtaCor Medical, Inc. hold?

AtaCor Medical, Inc. holds 31 US utility patents granted between 2017 and 2025, spanning 3 technology areas.

What is AtaCor Medical, Inc.'s Innovation Score?

AtaCor Medical, Inc. has an Innovation Score of 39.2 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does AtaCor Medical, Inc. focus on?

AtaCor Medical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 31 patents, ranking #123 of 1,943 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is AtaCor Medical, Inc.'s patent grant rate increasing or decreasing?

AtaCor Medical, Inc.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for AtaCor Medical, Inc.'s patents?

AtaCor Medical, Inc.'s patents average 21.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AtaCor Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

AtaCor Medical, Inc.

USPTO PatentsView assignee record - 31 granted patents across 3 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Atacor ranks #9,972 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 3 technology areas.

#9,972
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.2/100): 21.6
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9972 · US Corporation #9,972 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 31 grants
UPPER-Q #9,972/49,997
PHOTO-FINISH Anchor Packaging
CPC-NARROW A61N · 3 areas
INNOV-THIN 39.2/100
CLAIMS-DENSE 21.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Anchor Packaging, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Atacor’s 39.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.0 pts (31%) Velocity 8.1 pts (21%) Breadth 6.1 pts (16%) Claim depth 13.0 pts (33%)

Qualcomm Incorporated · highest

85
AtaCor Medical · this assignee

39
Drylock · near

39
Linde Hydraulics & KG · near

39
Lindsay Transportati… · near

39
Transfert Plus… · near

39
3D Lighting… · lowest

7

What this shows Atacor's Innovation Score is 39.2/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Atacor?

Each dot is one of Atacor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Atacor’s own 21.6 claims/patent is ABOVE the 11.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Atacor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Atacor's grants concentrate

AtaCor Medical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2020. By volume, Atacor sits between Anchor Packaging, LLC and Basf Agro Trademarks GmbH.

Atacor's three-year grant acceleration

AtaCor Medical, Inc. shows 11 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Anchor Packaging

31
Anello Photonics

31
Anova Applied

31
Antennas Direct

31
Atomic Design

31
Axonics

31
Bailey Nurseries

31
Basf Agro Tradema…

31
Atacor Medical ◀

31

What this shows AtaCor holds 31 patents at rank #9,972, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AtaCor

By rank, the assignees closest to #9,972 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in AtaCor's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for AtaCor, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), AtaCor ranks #123 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Lindsay Transportation Solutions, LLC 39 Transfert Plus, Société en Commandite 39 Linde Hydraulics GmbH & Co. KG 39 Drylock Technologies NV 39

Atacor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

AtaCor Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	6.5%
2018	2	6.5%
2019	4	12.9%
2020	1	3.2%
2021	4	12.9%
2022	1	3.2%
2023	3	9.7%
2024	7	22.6%
2025partial year	7	22.6%

Which technologies does AtaCor Medical, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 31

A61B - DIAGNOSIS; SURGERY; Identification 25

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AtaCor Medical, Inc.'s patent record in context - here's where to go next.

AtaCor Medical, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 100% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #9,972 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AtaCor Medical, Inc. against Anchor Packaging, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.